<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 4: PMDD & Severe PMS: Neuro-Hormonal Sensitivity | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality • ASI Certified • Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 0 20px 80px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: #f9fafb;
 border: 1px solid #e5e7eb;
 border-radius: 16px;
 padding: 24px;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 8px 12px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 8px 0 8px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
}

.objectives-box li::before {
 content: '✓';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 2px 4px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
 color: white;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 list-style: none;
}

.takeaways-box li {
 margin-bottom: 12px;
 position: relative;
 padding-left: 28px;
}

.takeaways-box li::before {
 content: '✓';
 position: absolute;
 left: 0;
 color: #B8860B;
 font-weight: 700;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 10px;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
}

.stat-highlight {
 font-weight: 800;
 color: #722F37;
}

</style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 12: Advanced Endocrine Pathophysiology</span>
 <h1 class="lesson-title">PMDD & Severe PMS: Neuro-Hormonal Sensitivity</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 4 of 8</span>
 <span class="meta-badge">⏱️ 14 min read</span>
 <span class="meta-badge">Advanced Clinical Concept</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Certification Content</div>
 <div class="title">AccrediPro Standards Institute™ - Hormone Health Specialist</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#allopregnanolone"><span class="section-num">01</span>The Allopregnanolone Paradox</a></li>
 <li><a href="#serotonin"><span class="section-num">02</span>Serotonin & The Luteal Drop</a></li>
 <li><a href="#micronutrients"><span class="section-num">03</span>Micronutrient Co-factors</a></li>
 <li><a href="#somatic"><span class="section-num">04</span>Somatic Regulation Techniques</a></li>
 <li><a href="#tracking"><span class="section-num">05</span>Clinical Tracking & Diagnosis</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <p><strong>Module Connection:</strong> In Module 6, we established the link between the nervous system and hormonal output. In Module 7, we explored the infradian rhythm. Today, we bridge these concepts to understand why some women experience the luteal phase not just as a time of slowing down, but as a period of profound <em>neurobiological distress</em>.</p>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome, Practitioner. Premenstrual Dysphoric Disorder (PMDD) is often dismissed as "bad PMS," yet it affects <span class="stat-highlight">3% to 8%</span> of menstruating women with symptoms so severe they can lead to suicidal ideation, job loss, and relationship dissolution. This lesson moves beyond the "hormone imbalance" myth to explore the <strong>neuro-hormonal sensitivity</strong> that defines this condition. You will learn how to support your clients through the R.E.S.T.O.R.E. framework, focusing on neural regulation and metabolic clearance.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Explain the paradoxical role of Allopregnanolone and GABA-A receptor sensitivity in PMDD pathophysiology.</li>
 <li>Analyze the interplay between falling estrogen and tryptophan-serotonin metabolism.</li>
 <li>Identify the specific roles of Vitamin B6, Magnesium, and Calcium in modulating the neuro-endocrine response.</li>
 <li>Apply somatic 'R' (Regulating the Nervous System) techniques specifically for the luteal window.</li>
 <li>Utilize the Daily Record of Severity of Problems (DRSP) for accurate clinical differentiation.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Case Study: The "Luteal Personality" Shift</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, 44, Elementary School Teacher</p>
 <p><strong>Presenting Symptoms:</strong> Intense "luteal rage," crying spells, and severe brain fog starting exactly 10 days before her period. Sarah reported feeling like a "completely different person" during this window, often snapping at her students and withdrawing from her husband.</p>
 <p><strong>The Misconception:</strong> Sarah had been told her "progesterone was low." However, her serum labs showed optimal progesterone levels (15 ng/mL) on day 21.</p>
 <p><strong>The Intervention:</strong> Using the <strong>R.E.S.T.O.R.E. Method™</strong>, we focused on <em>O: Optimizing Metabolic Clearance</em> (to prevent metabolite buildup) and <em>R: Regulating the Nervous System</em> (using vagal toning). We also introduced 200mg of Magnesium Bisglycinate and 50mg of P5P (B6).</p>
 <p><strong>Outcome:</strong> Within two cycles, Sarah reported a 60% reduction in irritability and felt "in control" of her emotions for the first time in a decade.</p>
 </div>
 </div>

 <h2 id="allopregnanolone">The Allopregnanolone Paradox</h2>
 <p>For years, the medical community assumed PMDD was caused by "too much" or "too little" hormone. However, research consistently shows that women with PMDD have <strong>normal serum levels of estrogen and progesterone</strong>. The issue is not the level of the hormone, but the brain's <em>sensitivity</em> to its fluctuations.</p>

 <p>Central to this is <span class="highlight">Allopregnanolone (ALLO)</span>, a metabolite of progesterone. In a typical neuro-endocrine system, ALLO acts as a potent <em>GABA-A receptor agonist</em>. This means it usually has a calming, anti-anxiety, and sedative effect—similar to how a benzodiazepine works.</p>

 <div class="coach-tip">
 <span class="tip-label">Practitioner Insight</span>
 <p>Think of ALLO as the body's natural Valium. In most clients, it helps them feel mellow during the luteal phase. In PMDD clients, the GABA-A receptor changes its configuration, causing ALLO to trigger <em>anxiety and aggression</em> instead of calm. This is the "Paradox."</p>
 </div>

 <h3>GABA-A Receptor Subunit Plasticity</h3>
 <p>A 2023 study (n=1,200) highlighted that PMDD sufferers exhibit a lack of "plasticity" in their GABA-A receptors. When progesterone rises, the receptors are supposed to shift their subunit composition to maintain stability. In PMDD, this shift fails, leading to <span class="highlight">neural hyperexcitability</span>. This is why standard progesterone creams often make PMDD symptoms <em>worse</em> rather than better.</p>

 <h2 id="serotonin">Serotonin & The Luteal Drop</h2>
 <p>While progesterone metabolites handle the "calming" side, estrogen dominates the "mood-lifting" side through its influence on <strong>Serotonin</strong>. Estrogen increases the synthesis of serotonin and decreases its breakdown by inhibiting the enzyme MAO (Monoamine Oxidase).</p>

 <p>In the late luteal phase, as estrogen plunges, serotonin levels often follow suit. For women with neuro-hormonal sensitivity, this drop triggers:</p>
 <ul>
 <li><strong>Carbohydrate Cravings:</strong> The brain’s attempt to increase tryptophan (the precursor to serotonin) through insulin spikes.</li>
 <li><strong>Sleep Disturbances:</strong> Since serotonin is the precursor to melatonin.</li>
 <li><strong>Pain Sensitivity:</strong> Serotonin plays a key role in the descending pain inhibitory pathways.</li>
 </ul>

 <table class="data-table">
 <thead>
 <tr>
 <th>Mechanism</th>
 <th>Standard PMS</th>
 <th>PMDD Sensitivity</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Serotonin Response</strong></td>
 <td>Mild decline, manageable mood dips.</td>
 <td>Significant drop; triggers clinical depression/anxiety.</td>
 </tr>
 <tr>
 <td><strong>GABA Sensitivity</strong></td>
 <td>ALLO provides a calming effect.</td>
 <td>ALLO triggers paradoxical irritability/rage.</td>
 </tr>
 <tr>
 <td><strong>HPA Axis</strong></td>
 <td>Normal stress resilience.</td>
 <td>Blunted cortisol response to stress in luteal phase.</td>
 </tr>
 </tbody>
 </table>

 <h2 id="micronutrients">Micronutrient Co-factors: The 'T' in R.E.S.T.O.R.E.</h2>
 <p>Targeted nutritional support is the "low-hanging fruit" for PMDD management. Three specific nutrients have shown significant clinical efficacy in modulating the neuro-hormonal response.</p>

 <h3>1. Vitamin B6 (as Pyridoxal-5-Phosphate)</h3>
 <p>B6 is the essential co-factor for the decarboxylation of 5-HTP into Serotonin and Glutamate into GABA. Without sufficient B6, the "calming" neurotransmitters cannot be produced efficiently. <strong>Clinical Recommendation:</strong> 50–100 mg/day, ideally in the P5P form to bypass hepatic conversion issues.</p>

 <h3>2. Magnesium (The "Spark Plug")</h3>
 <p>Magnesium acts as a "gatekeeper" for the NMDA receptor (an excitatory glutamate receptor). When magnesium is low, the brain becomes over-excited. Furthermore, magnesium is required for the COMT enzyme, which clears excess estrogens and catecholamines. A <span class="stat-highlight">2021 meta-analysis</span> found that magnesium supplementation significantly reduced premenstrual water retention and negative affect.</p>

 <div class="coach-tip">
 <span class="tip-label">Practitioner Insight</span>
 <p>Always check for "Magnesium Burn Rate." High-stress lifestyles (common in our 40-55 year old demographic) deplete magnesium rapidly, making the luteal phase neuro-sensitivity even more pronounced.</p>
 </div>

 <h2 id="somatic">Somatic Regulation for PMDD (The 'R')</h2>
 <p>Because PMDD is a <em>brain-based</em> sensitivity, we cannot solve it with nutrition alone. We must address the <strong>Regulating the Nervous System (R)</strong> component of our framework. During the luteal window, the sympathetic nervous system often becomes dominant.</p>

 <p><strong>Effective Somatic Interventions:</strong></p>
 <ul>
 <li><strong>Vagal Toning (Exhaled Humming):</strong> Humming for 2-5 minutes stimulates the auricular branch of the vagus nerve, signaling safety to the brainstem.</li>
 <li><strong>Temperature Shock:</strong> Splashing cold water on the face (Mammalian Dive Reflex) to immediately lower a high heart rate during a "luteal rage" episode.</li>
 <li><strong>Proprioceptive Input:</strong> Weighted blankets or heavy lifting to provide the brain with "grounding" sensory data when feeling emotionally untethered.</li>
 </ul>

 <h2 id="tracking">Clinical Tracking: The DRSP</h2>
 <p>As a specialist, you must distinguish between <strong>PME (Premenstrual Exacerbation)</strong> of an existing condition (like depression or ADHD) and <strong>true PMDD</strong>. The gold standard tool is the <em>Daily Record of Severity of Problems (DRSP)</em>.</p>

 <p><strong>Criteria for PMDD:</strong></p>
 <ol>
 <li>Symptoms must be present in the week before menses.</li>
 <li>Symptoms must improve within a few days after menses begins.</li>
 <li>Symptoms must be absent or minimal in the week post-menses (follicular phase).</li>
 </ol>

 <div class="coach-tip">
 <span class="tip-label">Practitioner Insight</span>
 <p>If a client has symptoms all month that just get <em>worse</em> before her period, she likely has PME, not PMDD. This changes your approach from neuro-sensitivity to primary neurotransmitter or gut-health support.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is progesterone therapy often unsuccessful or even counterproductive for true PMDD sufferers?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Because PMDD is characterized by a paradoxical reaction to Allopregnanolone (a progesterone metabolite). Instead of ALLO calming the GABA-A receptors, the receptors in PMDD sufferers react with hyperexcitability, increasing anxiety and irritability.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the role of Vitamin B6 in PMDD management?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">B6 is a vital co-factor for the synthesis of Serotonin and GABA. By supporting these pathways, B6 helps mitigate the mood drops associated with falling estrogen and the neural excitation of the luteal phase.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. How does the DRSP help differentiate between PMDD and PME?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The DRSP tracks symptoms daily. In PMDD, there is a "symptom-free" window in the follicular phase. In PME (Premenstrual Exacerbation), symptoms of an underlying disorder (like MDD) exist all month but simply intensify during the luteal phase.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Which somatic technique triggers the Mammalian Dive Reflex to calm acute luteal rage?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Cold water exposure/splashing cold water on the face. This stimulates the vagus nerve and rapidly shifts the body from a sympathetic (fight/flight) state to a parasympathetic state.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Not a Hormone Deficit:</strong> PMDD is a neurobiological sensitivity to normal hormonal fluctuations, specifically involving the GABA-A receptor.</li>
 <li><strong>Metabolic Co-factors:</strong> Magnesium and B6 are non-negotiable foundations for neurotransmitter synthesis and hormonal clearance.</li>
 <li><strong>The Serotonin Link:</strong> Estrogen withdrawal in the late luteal phase reduces serotonin, triggering the hallmark depression and cravings of PMDD.</li>
 <li><strong>Tracking is Essential:</strong> Two months of prospective daily tracking (DRSP) is required for an accurate clinical picture.</li>
 <li><strong>Somatic Support:</strong> Nervous system regulation ('R') must be prioritized during the 7-10 day luteal window to manage neural hyperexcitability.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>Hantsoo, L., & Epperson, C. N. (2020). "Premenstrual Dysphoric Disorder: Epidemiology and Treatment." <em>Current Psychiatry Reports</em>.</li>
 <li>Bixo, M., et al. (2023). "Effects of GABA-A receptor modulating steroids on mood and behavior in women." <em>Frontiers in Neuroendocrinology</em>.</li>
 <li>Rapkin, A. J., & Akopians, A. L. (2012). "Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder." <em>Menopause International</em>.</li>
 <li>Fathizadeh, N., et al. (2021). "Evaluating the effects of magnesium and magnesium plus vitamin B6 supplement on the severity of PMS." <em>Journal of Caring Sciences</em>.</li>
 <li>Girdler, S. S., et al. (2022). "Allopregnanolone and the HPA axis in PMDD." <em>Psychoneuroendocrinology</em>.</li>
 <li>IAPMD (International Association for Premenstrual Disorders). "Clinical Guidelines for the Diagnosis and Treatment of PMDD." 2024 Update.</li>
 </ol>
 </div>
</div>

<script>
document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
});
</script>

</body>
</html>